TTK Healthcare Limited

TTKHLTCARE

INE910C01018

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:50 2024-04-26 am EDT			5-day change	1st Jan Change
1,588 ^INR	-1.13%		+5.14%	+12.65%

Feb. 02	TTK Healthcare Limited Appoints S Kalyanaraman as Chief Executive Officer, Effective 1 June, 2024	CI
Feb. 02	TTK Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

TT Krishnamachari & Co., Ltd., T T Jagannathan, and T T Raghunathan cancelled the acquisition of remaining 26.888% shares in TTK Healthcare Limited.

July 27, 2023

TT Krishnamachari & Co., Ltd., T T Jagannathan, and T T Raghunathan, made an offer to acquire remaining 26.888% shares in TTK Healthcare Limited (BSE:507747) on April 5, 2023. The acquirers have an intention to take the company private. Inga Ventures Pvt. Ltd. acted as the manager to the offer. A.K. Jain & Associates acted as an accountant and Link Intime India Pvt. Ltd. acted as registrar to TTK Healthcare. As of April 20, 2023, the transaction has been approved by the board of TTK Healthcare Limited.

TT Krishnamachari & Co., Ltd., T T Jagannathan, and T T Raghunathan cancelled the acquisition of remaining 26.888% shares in TTK Healthcare Limited (BSE:507747) on July 28, 2023.

Latest news about TTK Healthcare Limited

TTK Healthcare Limited Appoints S Kalyanaraman as Chief Executive Officer, Effective 1 June, 2024	Feb. 02	CI
TTK Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 02	CI
TTK Healthcare's Production at Chennai, Unit Disrupted Due to Floods	Dec. 06	MT
TTK Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 03	CI
TTK Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 03	CI
TTK Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-01	CI
TT Krishnamachari & Co., Ltd., T T Jagannathan, and T T Raghunathan cancelled the acquisition of remaining 26.888% shares in TTK Healthcare Limited.	23-07-27	CI
TTK Healthcare Revises Floor Price for Delisting	23-07-14	MT
India's Mankind Pharma posts 43% jump in Q4 profit in first results since listing	23-05-30	RE
TTK Healthcare Logs Higher Net Profit in Fiscal Q4	23-05-24	MT
TTK Healthcare Limited Proposes Dividend for the Financial Year Ended 31St March, 2023	23-05-23	CI
TTK Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-23	CI
TT Krishnamachari & Co., Ltd., T T Jagannathan, and T T Raghunathan, made an offer to acquire remaining 26.888% shares in TTK Healthcare Limited.	23-04-04	CI
TTK Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-07	CI
TTK Healthcare Posts Decline in Fiscal Q2 Consolidated Net Profit	22-10-28	MT
India's TTK Healthcare Q2 profit more than doubles on higher sales of medical devices	22-10-28	RE
TTK Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-28	CI
TTK Healthcare Appoints New Chairman	22-09-09	MT
TTK Healthcare Limited Announces Board Changes	22-09-09	CI
TTK Healthcare Limited Approves Dividend for the Year Ended March 31, 2022	22-08-03	CI
TTK Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-26	CI
TTK Healthcare Launches Sexual Pleasure E-Store	22-06-29	MT
Indian shares fall as metals tumble; automobiles help cap losses	22-05-23	RE
TTK Healthcare Limited Approves Dividend for the Financial Year Ended 31 March, 2022	22-05-23	CI
TTK Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-23	CI

Chart TTK Healthcare Limited

Duration

Period

More charts

Company Profile

TTK Healthcare Limited is an India-based healthcare company. The Companyâs segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, Others and Human Pharma. The Animal Welfare segment includes products for veterinary use. The Consumer products comprise marketing and distribution of Eva range of cosmetics, Woodwardâs gripe water, good home range of scrubbers, air fresheners and others. The Medical Devices segment comprises manufacturing and marketing of artificial heart valves, orthopedic implants and others. The Protective Devices segment comprises manufacturing and marketing of male contraceptives and other allied products. The Foods segment comprises manufacturing and marketing of Food Products. The Others segment includes printing and publishing of maps and atlases. The Human Pharma segment includes products for human use. It has approximately 30 product categories and services with 16 manufacturing units.

Sector

Pharmaceuticals

Calendar

2024-05-21 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
TTK HEALTHCARE LIMITED	+12.65%	269M
MCKESSON CORPORATION	+17.35%	71.39B
CARDINAL HEALTH, INC.	+2.39%	25.1B
SINOPHARM GROUP CO. LTD.	+5.38%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.19B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
EBOS GROUP LIMITED	-3.38%	3.93B
GALENICA AG	-2.61%	3.86B